The most important task before winter arrives is harvesting, ensuring that nothing is wasted in what amounts to an entire season of work. Gathering and preparing all the produce for market or storage ...

The Census Bureau plans to use U.S. postal workers as census takers in at least two locations during field tests next year for the 2030 census, which will determine political power and federal funding ...

For a guy in charge of local schools, Oklahoma State Superintendent Ryan Walters generates an unusual amount of national news. This week, Walters announced a plan to create chapters of Turning Point ...

The Altoona Water Authority at a recent meeting authorized the transfer of 15 tons of the Class A soil amendment that it produces with its anaerobic digester and dryer to an employee who is a farmer, ...

PARIS, FRANCE - AUGUST 8: Diribe Welteji of Team Ethiopia competes during the Women’s 1500m Semi-Final on day thirteen of the Olympic Games Paris 2024 at Stade de France on August 8, 2024 in Paris, ...

Visibly, which has the first federally approved online vision test, has acquired Easee, a European digital eye care company. The move gives Chicago-based Visibly an entrance into the European health ...

Please provide your email address to receive an email when new articles are posted on . Angling a patient’s face can negate the effect of facial contour on visual field testing. AI may help predict ...

HARRIS COUNTY, Texas (KTRK) -- A Harris County Sheriff's Office sergeant was caught on video struggling to walk during a field sobriety test early Sunday, leading to his arrest on suspicion of driving ...

Eyebot, a startup offering a 90-second vision test kiosk that delivers doctor-verified glasses prescriptions, has secured $20 million in Series A funding. The Boston-based startup, founded in 2021, ...

Scientists are developing a surgery-free alternative to LASIK that reshapes the cornea using electricity instead of lasers. In rabbit tests, the method corrected vision in minutes without incisions. A ...

A Vertex Pharmaceuticals drug viewed as a successor to a non-opioid pill that won a landmark FDA approval earlier this year has failed a mid-stage clinical trial, dealing a setback to the company’s ...